Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis

Clinical Infectious Diseases

Volumn 45, Issue 6, 2007, Pages 779-784

  Tourret, Jérôme ^a,b,c   Tostivint, Isabelle ^a   Du Montcel, Sophie Tézenas ^a   Karie, Svetlana ^a   Launay Vacher, Vincent ^a   Vigneau, Cécile ^a   Bessette, Christel ^a   Deray, Gilbert ^a   Bagnis, Corinne Isnard ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; ENFUVIRTIDE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONTRAINDICATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; SURVIVAL RATE; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; FRANCE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; KAPLAN-MEIERS ESTIMATE; MEDICATION ERRORS; PROSPECTIVE STUDIES; RENAL DIALYSIS; STAVUDINE; ZIDOVUDINE;

EID: 34548496263     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521168     Document Type: Article

References (10)

1. Purdy BD, Raymond AM, Lesar TS. Antiretroviral prescribing errors in hospitalized patients. Ann Pharmacother 2000; 34:833-8.
2. DeLorenze GN, Follansbee SF, Nguyen DP, et al. Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events. Med Care 2005; 43:11163-68.
3. Rastegar DA, Knight AM, Monolakis JS. Antiretroviral medication errors among hospitalized patients with HIV infection. Clin Infect Dis 2006; 43:933-8.
4. Vigneau C, Guiard-Schmid JB, Tourret J, et al. The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002. Kidney Int 2005; 67:1509-14.
5. Tourret J, Tostivint I, Tézenas du Montcel S, et al. Outcome and prognosis factors in HIV infected hemodialyzed patients. Clin J Am Soc Nephrol 2006; 1:1241-7.
6. Berns J, Kasbekar N. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists. Clin J Am Soc Nephrol 2006; 1:117-29.
7. Izzedine H, Launay-Vacher V, Baumelou A, et al. An appraisal of antiretroviral drugs in hemodialysis. Kidney Int 2001; 60:821-30.
8. Izzedine H, Launay-Vacher V, Deray G. GPR antiviraux. 2nd ed. Paris: Méditions International Press, 2003.
9. Izzedine H, Launey-Vacher V, Deray G. The bright guide for antiretroviral agents. 1st ed. Coral Gables, FL: The Gilmar Company Press, 2003.
10. Ahuja TS, Borucki M, Grady J. Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. Am J Kidney Dis 2000; 36:574-80.